Literature DB >> 24594192

The effect of hyperglycaemia on permeability and the expression of junctional complex molecules in human retinal and choroidal endothelial cells.

S Saker1, E A Stewart2, A C Browning3, C L Allen4, W M Amoaku5.   

Abstract

Diabetic retinopathy is the leading cause of preventable blindness in the working population and its prevalence continues to increase as the worldwide prevalence of diabetes grows. Diabetic choroidopathy is less well studied and occurs in the late stages of diabetic eye disease. The main cause of visual loss in diabetic eye disease is diabetic macular oedema caused by an increase in microvascular endothelial permeability. Endothelial cell permeability is influenced by multiple factors which have not been fully elucidated, particularly in human models. In addition, the gene and protein expression between retinal and choroidal endothelial cells, even in humans, has been shown to be heterogeneous. The aim of this project was to determine, in vitro, the effect of high glucose (25 mM) on human paracellular permeability in retinal and choroidal endothelial cells. The expression of selected tight junction molecules (Occludin, Claudin-5, JAM-A and JAM-C) and adheren junction (VE-Cadherin) molecules was also compared between retinal and choroidal endothelial cells and with high glucose. High glucose conditions significantly increased the permeability in both retinal and choroidal endothelial cells monolayers although the increase was higher in retinal endothelial cells. Under normal glucose culture conditions microarray analysis determined that occludin and claudin-5 gene expression was higher in retinal endothelial cells than choroidal endothelial cells, and western blotting indicated that claudin-5 protein expression was also higher in retinal endothelial cells whilst JAM-A, and C and VE-Cadherin levels were similar. In retinal endothelial cells exposed to high glucose claudin-5, occludin and JAM-A was found to be reduced, whereas the expression of VE-Cadherin and JAM-C was unchanged when evaluated with western blotting, immunofluorescence and qPCR. None of the proteins were significantly decreased by high glucose in choroidal endothelial cells. The increase in retinal endothelial cell permeability is likely caused by a decrease in selective tight junction protein expression, leading to increased paracellular permeability. This may indicate differences in junctional molecule regulation of permeability in retinal compared to choroidal endothelial cells.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  claudin-5; junctional adhesion molecule (JAM); macular oedema; occludin; permeability; proliferation; tight junction; vascular

Mesh:

Substances:

Year:  2014        PMID: 24594192     DOI: 10.1016/j.exer.2014.02.016

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  16 in total

1.  miR-15a/16 inhibits TGF-beta3/VEGF signaling and increases retinal endothelial cell barrier proteins.

Authors:  Eun-Ah Ye; Li Liu; Jena J Steinle
Journal:  Vision Res       Date:  2017-08-07       Impact factor: 1.886

2.  Diabetic retinal pigment epitheliopathy: fundus autofluorescence and spectral-domain optical coherence tomography findings.

Authors:  Eui Chun Kang; Yuri Seo; Suk Ho Byeon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-06       Impact factor: 3.117

3.  Differential expression of breast cancer-resistance protein, lung resistance protein, and multidrug resistance protein 1 in retinas of streptozotocin-induced diabetic mice.

Authors:  Meng-Shuang Li; Meng Xin; Chuan-Long Guo; Gui-Ming Lin; Jun Li; Xiang-Gen Wu
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

4.  Involvement of RhoA/ROCK1 signaling pathway in hyperglycemia-induced microvascular endothelial dysfunction in diabetic retinopathy.

Authors:  Qian-Yi Lu; Wei Chen; Li Lu; Zhi Zheng; Xun Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

5.  Targeting human 8-oxoguanine DNA glycosylase to mitochondria protects cells from high glucose-induced apoptosis.

Authors:  Yu-Ling Zou; Wen-Bin Luo; Lin Xie; Xin-Bang Mao; Chao Wu; Zhi-Peng You
Journal:  Endocrine       Date:  2018-03-21       Impact factor: 3.633

Review 6.  A review of therapies for diabetic macular oedema and rationale for combination therapy.

Authors:  W M K Amoaku; S Saker; E A Stewart
Journal:  Eye (Lond)       Date:  2015-06-26       Impact factor: 3.775

7.  Hydrogen Sulfide Is a Novel Protector of the Retinal Glycocalyx and Endothelial Permeability Barrier.

Authors:  Claire L Allen; Katarzyna Wolanska; Naseeb K Malhi; Andrew V Benest; Mark E Wood; Winfried Amoaku; Roberta Torregrossa; Matthew Whiteman; David O Bates; Jacqueline L Whatmore
Journal:  Front Cell Dev Biol       Date:  2021-09-07

8.  Angiogenic and Immunologic Proteins Identified by Deep Proteomic Profiling of Human Retinal and Choroidal Vascular Endothelial Cells: Potential Targets for New Biologic Drugs.

Authors:  Justine R Smith; Larry L David; Binoy Appukuttan; Phillip A Wilmarth
Journal:  Am J Ophthalmol       Date:  2018-03-17       Impact factor: 5.258

Review 9.  A Revised Hemodynamic Theory of Age-Related Macular Degeneration.

Authors:  Bradley D Gelfand; Jayakrishna Ambati
Journal:  Trends Mol Med       Date:  2016-07-13       Impact factor: 11.951

10.  The effects of pleiotrophin in proliferative diabetic retinopathy.

Authors:  Xuemei Zhu; Yujing Bai; Wenzhen Yu; Chungting Pan; Enzhong Jin; Dan Song; Qiong Xu; Yuou Yao; Lvzhen Huang; Yong Tao; Xiaoxin Li; Mingwei Zhao
Journal:  PLoS One       Date:  2015-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.